Table 1.
Characteristics of study participants by NAFLD category
| Glucagon (pg/mL) | |||||
|---|---|---|---|---|---|
| Characteristic | Q1 (≤115.31) | Q2 (115.32–154.12) | Q3 (154.13–201.99) | Q4 (>202) | P for trend |
| N | 1029 | 1029 | 1029 | 1028 | |
| Age, year | 67.29 ± 8.96 | 67.61 ± 8.88 | 67.84 ± 8.21 | 66.76 ± 8.82 | 0.266 |
| Men, % | 28.01 | 26.12 | 23.83 | 22.04 | <0.001 |
| Duration of diabetes, year | 10.68 ± 8.53 | 9.83 ± 7.6 | 10.34 ± 7.97 | 9.97 ± 7.92 | 0.164 |
| Current smoking, % | 17.01 | 16.03 | 14.29 | 15.18 | 0.946 |
| Platelet count, *109/L | 210.11 ± 58.18 | 214.39 ± 57.75 | 212.39 ± 57.59 | 216.37 ± 57.82 | 0.038 |
| Albumin, g/dL | 44.48 ± 2.74 | 44.46 ± 2.63 | 44.43 ± 2.71 | 44.48 ± 2.68 | 0.930 |
| AST/ALT | 1.17 ± 0.36 | 1.16 ± 0.39 | 1.16 ± 0.42 | 1.17 ± 0.43 | 0.921 |
| BMI, kg/m2 | 24.71 ± 3.49 | 25.16 ± 3.73 | 24.99 ± 3.54 | 25.03 ± 3.77 | 0.119 |
| Waist circumference, cm | 89.55 ± 9.84 | 90.58 ± 9.94 | 90.2 ± 9.66 | 90.25 ± 9.59 | 0.210 |
| FPG, mmol/L | 7.83 ± 2.36 | 7.74 ± 2.34 | 7.72 ± 2.41 | 7.77 ± 2.59 | 0.571 |
| HbA1c, % | 7.51 ± 1.34 | 7.49 ± 1.4 | 7.48 ± 1.38 | 7.52 ± 1.42 | 0.899 |
| HbA1c, mmol/mol | 58.58 ± −8.85 | 58.36 ± −8.2 | 58.25 ± −8.42 | 58.69 ± −7.98 | |
| SBP, mmHg | 143.57 ± 19.6 | 146.33 ± 19.83 | 144.49 ± 19.68 | 145.14 ± 19.78 | 0.307 |
| DBP, mmHg | 78.24 ± 10.4 | 78.94 ± 11.18 | 78.54 ± 10.9 | 78.57 ± 10.47 | 0.703 |
| Total cholesterol, mmol/L | 5.03 ± 1.19 | 5 ± 1.19 | 5.17 ± 1.2 | 5.25 ± 1.17 | <0.001 |
| Triglycerides, mmol/L | 1.83 ± 1.42 | 1.88 ± 1.39 | 1.9 ± 1.57 | 1.93 ± 1.45 | 0.119 |
| HDL-C, mmol/L | 1.18 ± 0.29 | 1.19 ± 0.28 | 1.23 ± 0.3 | 1.23 ± 0.3 | <0.001 |
| LDL-C, mmol/L | 3.14 ± 0.85 | 3.08 ± 0.84 | 3.18 ± 0.86 | 3.24 ± 0.84 | <0.001 |
| Hypertension, % | 76.48 | 83.67 | 76.38 | 78.5 | 0.829 |
| Dyslipidemia, % | 62.49 | 59.86 | 60.84 | 65.18 | 0.182 |
The data are summarized as the mean ± SD for continuous variables or as a percentage for categorical variables. P for trend was calculated by regression analysis.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; DBP; diastolic blood pressure; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein; LDL-C, low-density lipoprotein; NAFLD, nonalcoholic fatty liver disease; SBP, systolic blood pressure.